ArticleGeroScience2024

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease.

Seong-Jin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.